Unknown

Dataset Information

Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications.


ABSTRACT: Antiphospholipid syndrome (APS) is an acquired thromboinflammatory disorder characterized by the presence of antiphospholipid antibodies as well as an increased frequency of venous or arterial thrombosis and/or obstetrical morbidity. The spectrum of disease varies from asymptomatic to a severe form characterized by widespread thrombosis and multiorgan failure, termed catastrophic APS (CAPS). CAPS affects only about ∼1% of APS patients, often presents as a thrombotic microangiopathy and has a fulminant course with >40% mortality, despite the best available therapy. Animal models have implicated complement in the pathophysiology of thrombosis in APS, with more recent data from human studies confirming the interaction between the coagulation and complement pathways. Activation of the compleme

SUBMITTER: Chaturvedi S 

PROVIDER: S-EPMC8080439 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature